FATE icon

Fate Therapeutics
FATE

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$6
426% upside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
HC Wainwright & Co
HC Wainwright & Co
Robert Burns
0% 1-yr FATE win rate
31 Oct ‘25 1 month ago
Wedbush
Wedbush
David Nierengarten
0% 1-yr FATE win rate
27 Oct ‘25 1 month ago
Needham
Needham
Gil Blum
27 Oct ‘25 1 month ago